Today is the day we make a difference

PurpleSun was founded with a singular goal: to transform healthcare. We make an impact by building technologies that harness the power of ultraviolet light to create a sustainable solution for improving quality and preventing Hospital-Acquired Infections.

PurpleSun, The Horizon

PurpleSun is a venture-backed commercial healthcare technology company based out of New York. We are focused on providing smart, light-based technology solutions to the healthcare industry for infection prevention.

Our company’s novel light technology platform will be utilized throughout the continuum of care, within hospitals, long term care, and surgical centers. The smart devices will set the stage for patient safety through the highest of quality in medical equipment disinfection.

Our goal is to prevent healthcare-acquired infections, which will ultimately save lives, reduce costs, and enhance safety for patients and caregivers. Our clinical data proves best in class efficacy and performance of our platform, and positions PurpleSun to illuminate the healthcare arena.



PurpleSun Prepared #PSP A mindfulness that involves a sense of awareness through preparation and perseverance enabling success in an ever-changing environment.



To create the standard for light disinfection technology. We aim to advance the science of FMUV to demonstrate a new paradigm that pushes the boundaries beyond currently acceptable practices, and to become the World’s leading brand in sustainable solutions for quality and infection prevention for patients, staff and hospitals.



Sustainable impact to the quality of care for the healthiest patient-ready environment.



Our History



Birth of a company that will transform healthcare

Grand Prize WINNERS NYS Business Plan

Named one of the Top 50 most promising startups from around the World



Endorsement from CTO of Health and Human Services

Invited member to the White House CEO Healthcare and Innovation Forum


2012 - 2013

Secured angel investments to move from concept to pre-commercial build



First abstract submitted and published in IDSA 2014, demonstrating superior efficacy with 90-second disinfection cycles



International patent app published w/ strong position

2nd Abstract published w/ successful clinical performance data



Strategic Partnership with Northwell Health, the 12th largest healthcare system in the US



3-month onsite trainings and product design evaluations

Completed Pre-Commercial System



Clinical trials successfully completed

PurpleSun is featured in Wall Street Journal “Game Changers in Health Tech”

American Journal of Infection Control - PurpleSun FMUV Publications



Partnership with Hackensack Meridian

Commercially operational w/ sales team expansion

The Team
  • Romo

    Luis F. Romo

    Founder & CEO
  • Kowalksi

    Dr. Wladyslaw Kowalski

    Chief Scientist, World Ultraviolet Expert, 
    & Co-Founder
  • McNicholas

    Audrey McNicholas

    VP, Operations & Co-Founder
  • Dromms

    Ray Dromms

    VP, Manufacturing Operations
Clinical Advisors
  • Walsh

    Dr. Thomas Walsh

    Director, Infectious Disease Weill Cornell Medicine
  • Vidmantas

    Dr. Vidmantas Petraitis

    Assistant Professor of Research in Medicine at Weill Cornell Medicine
  • Petraitiene

    Dr. Ruta Petraitiene

    Senior Research Associate in Medicine at Weill Cornell Medicine
  • Strods

    Sal Strods

    R&D Advisor Formerly, VP WelchAllyn
  • Gruber

    Bill Gruber

    Sales and Marketing Advisor CEO, Solace Therapeutics

In The Press